Matt Buck

Time DOES matter, especially when treating our littlest patients #pediatricurology @YaleMed @JustinVNguyenMD @PatrickKenneyMD

@Adam_Weiner535 @Uro_Res @AmerUrological @UroAcademic @Uro_Stream @UrologyTimes @DrSCohen @KGUROmd @JAMANetworkOpen @JAMANetwork Signals work! Still looks like the interview is king, but signals are taken seriously. Love to see MICE in the uro literature

Preference signaling in #uromatch increased 📈 odds of getting an interview by 6-fold‼️ @Uro_Res @AmerUrological @UroAcademic @Uro_Stream @UrologyTimes @DrSCohen @KGUROmd @JAMANetworkOpen @JAMANetwork tinyurl.com/3n8eaf73

On March 18, our friend and co-resident @ChrisAlabastro was struck by a car We all know Chris as a wonderful, caring person. We started this GoFundMe to assist Chris and his family during these difficult times Thank you so much. -@NM_Urology Residents gofund.me/09968df0

@MatthewBBuck @Ghiraldi_EM @BenjaminKannMD @jamesbyu @dr_sprenkle "This study raises thought-provoking questions about how and why therapeutic decisions are novel approaches to care." - @M_Koelker, Zhiyu Qian & @Putnam_Cole Full Editorial➡️auajournals.org/doi/full/10.10…

"Facility-Level Variation in Use of Locoregional Therapy for Metastatic #ProstateCancer" Article➡️ ow.ly/3GE450Iejfg Authors: @MatthewBBuck, @Ghiraldi_EM, Patrick Demkowicz, Henry S. Park, Yi An, @BenjaminKannMD, @jamesbyu, @dr_sprenkle, Isaac Y. Kim & Michael S. Leapman

Our awesome alums (@MatthewBBuck @DylanHeckscher) have worked on innovative projects to improve clinical outcomes, including reducing surgical site infections, venous thromboembolism, time to OR for patients with testicular detorsion.

My fellowship was amazing. I had such a wonderful experience, learned so much, and met incredible mentors in @PatrickKenneyMD, @mleapman, @CMSE_JCavallo. Please feel free to ask me any questions!

Fantastic opportunity for students interested in urology. Please feel free to reach out with any questions

We would like to introduce @JEFFUrology Class of 2027 - Matthew Buck (@FrankNetterMD), David Fu (@unmc) and Carlos Perez (@UMNews)! Welcome to the family! @AmerUrological #AUAMatch #Uromatch #AUAmatch2022 @UroAcademic @MidAtlanticAUA

@DrMotamedinia @Yale_Urology @PatrickKenneyMD @JustinVNguyenMD @mleapman @CMSE_JCavallo Thank you so much @DrMotamedinia! So kind of you to share. I'm so happy to be a part of all the amazing work with @Yale_Urology, and to talk about our findings!

Watch out for MS4 @MatthewBBuck on the #uromatch trail. Great job presenting his work w/us - improving compliance for in-office procedure abx ppx & reducing door2detorsion time #neaua21 @Yale_Urology @PatrickKenneyMD @JustinVNguyenMD @mleapman @CMSE_JCavallo

Oral GnRH Antagonists such as Relugolix (Orgovyx) May be More Expensive than Injectable LHRH Agonists such as Lupron. Does the Reduced Risk of Major Adverse Cardiac Events (approx. 50%) Seen in the HERO Trial Justify the Additional Cost?

@SbrtSean The count of the day was 8!

@SbrtSean Excited to see the responses! Thank you so much Dr. Collins for creating the poll! And so many thanks to @mleapman for his mentorship & guidance

Matthew Buck is a Smart MS4 from Quinnipiac University who is Interested in Urology. He is Rotating with Us Today and Asked “Who Makes the Decision on Whether or Not to Treat the Prostate in Low Burden Metastatic Prostate Cancer?”

Tonight, we celebrate our graduating residents and fellows, we welcome our incoming Chair, residents and fellows, and we say 'see you later' to our departing faculty! #graduation

@DrMotamedinia @FNetterMD @Yale_Urology @PatrickKenneyMD @mleapman Thank you so much Dr. Motamedinia! So great to work with so many people like yourself that are so invested in quality care

@MatthewBBuck (sub-I, all star Yale Uro Quality Fellow, @FNetterMD student) - speaking on #quality care in medicine, highlighting his work with us @Yale_Urology to reduce door-2-detorsion time @PatrickKenneyMD @mleapman

@wrhsiang @UCSFUrology @Yale @UroResidency @Uro_Res @AmerUrological Congrats Walter!